{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:39:34Z","timestamp":1788705574600,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T00:00:00Z","timestamp":1546732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s42358-018-0045-5","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T17:39:58Z","timestamp":1546796398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients"],"prefix":"10.1186","volume":"59","author":[{"given":"Juliana Fernandes Sarmento","family":"Donnarumma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloara Vieira Machado","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaquelina","family":"Ota-Arakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-5305","authenticated-orcid":false,"given":"Cristiane","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,6]]},"reference":[{"key":"45_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Sytemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"45_CR2","doi-asserted-by":"crossref","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, KhannaD KM, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;(62 Suppl):D42\u201350.","DOI":"10.1016\/j.jacc.2013.10.032"},{"key":"45_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"45_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1191\/0961203305lu2206oa","volume":"14","author":"N Gali\u00e8","year":"2005","unstructured":"Gali\u00e8 N, Manes A, Farahani KV, Pelino F, Palazzini M, Negro L, et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus. 2005;14:713\u20137.","journal-title":"Lupus"},{"issue":"123","key":"45_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1183\/09059180.00008211","volume":"21","author":"MD McGoon","year":"2012","unstructured":"McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21(123):8\u201318.","journal-title":"Eur Respir Rev"},{"key":"45_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1183\/09031936.00092306","volume":"30","author":"AJ Peacock","year":"2007","unstructured":"Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104\u20139.","journal-title":"Eur Respir J"},{"key":"45_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1183\/09059180.00003811","volume":"20","author":"SR Johnson","year":"2011","unstructured":"Johnson SR, Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev. 2011;20:277\u201386.","journal-title":"Eur Respir Rev"},{"key":"45_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1378\/chest.10-0260","volume":"138","author":"L Chung","year":"2010","unstructured":"Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest. 2010;138:1383\u201394.","journal-title":"Chest"},{"key":"45_CR9","first-page":"985","volume":"188","author":"C Haas","year":"2004","unstructured":"Haas C. Pulmonary hypertension associated with systemic lupus erythematosus. Bull Acad Natl Med. 2004;188:985\u201397.","journal-title":"Bull Acad Natl Med"},{"key":"45_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0961203307087188","volume":"17","author":"J Pope","year":"2008","unstructured":"Pope J. An update in pulmonary hypertension in systemic lupus erythematosus \u2013 do we need to know about it? Lupus. 2008;17:274\u20137.","journal-title":"Lupus"},{"key":"45_CR11","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","volume":"48","author":"A Prabu","year":"2009","unstructured":"Prabu A, Patel K, Yee CS, Nightingale P, Situnayake RD, Thickett DR, et al. Prevalence and risk factors of pulmonary arterial hypertension in patients with lupus. Rheumatology. 2009;48:1506\u201311.","journal-title":"Rheumatology"},{"key":"45_CR12","first-page":"918","volume":"16","author":"JS Simonson","year":"1989","unstructured":"Simonson JS, Schiller NB, Petri M, Hellman DB. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1989;16:918\u201325.","journal-title":"J Rheumatol"},{"key":"45_CR13","first-page":"836","volume":"28","author":"E Fo\u00efs","year":"2010","unstructured":"Fo\u00efs E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol. 2010;28:836\u201341.","journal-title":"Clin Exp Rheumatol"},{"key":"45_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0961203311429815","volume":"21","author":"SL Chow","year":"2012","unstructured":"Chow SL, Chandran V, Fazelzad R, Johnson SR. Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension. Lupus. 2012;21:353\u201364.","journal-title":"Lupus"},{"key":"45_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.autrev.2015.11.012","volume":"15","author":"J Qian","year":"2016","unstructured":"Qian J, Wang Y, Huang C, Yang X, Zhao J, Wang Q, et al. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: a PRISMA-compliant systematic review and meta-analysis. Autoimmun Rev. 2016;15:250\u20137.","journal-title":"Autoimmun Rev"},{"key":"45_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OARRR.S123549","volume":"9","author":"K Tselios","year":"2016","unstructured":"Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol. 2016;9:1\u20139.","journal-title":"Open Access Rheumatol"},{"key":"45_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","volume":"179","author":"R Condliffe","year":"2009","unstructured":"Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179:151\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"45_CR18","doi-asserted-by":"crossref","unstructured":"Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. Clin Dev Immunol 2012;2012:854\u2013941.","DOI":"10.1155\/2012\/854941"},{"key":"45_CR19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00296-011-1880-4","volume":"32","author":"F Lian","year":"2012","unstructured":"Lian F, Chen D, Wang Y, Ye Y, Wang X, Zhan Z, et al. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatol Int. 2012;32:1727\u201331.","journal-title":"Rheumatol Int"},{"key":"45_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002761","volume":"95","author":"C Huang","year":"2016","unstructured":"Huang C, Li M, Liu Y, Wang Q, Guo X, Zhao J, et al. Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. Medicine (Baltimore). 2016;95:e2761.","journal-title":"Medicine (Baltimore)"},{"key":"45_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.rbr.2014.09.003","volume":"55","author":"EJ Souza","year":"2015","unstructured":"Souza EJ, Kayser C. Nailfold capillaroscopy: relevance to the practice of rheumatology. Rev Bras Reumatol. 2015;55:264\u201371.","journal-title":"Rev Bras Reumatol"},{"key":"45_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2007.087353","volume":"68","author":"HM Hofstee","year":"2009","unstructured":"Hofstee HM, Vonk Noordegraaf A, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis. 2009;68:191\u20135.","journal-title":"Ann Rheum Dis"},{"key":"45_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/ket168","volume":"52","author":"V Riccieri","year":"2013","unstructured":"Riccieri V, Vasile M, Iannace N, Stefanantoni K, Sciarra I, Vizza CD, et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. Rheumatology. 2013;52:1525\u20138.","journal-title":"Rheumatology"},{"key":"45_CR24","first-page":"81","volume":"16","author":"YY Ong","year":"1998","unstructured":"Ong YY, Nikoloutsopoulos T, Bond CP, Smith MD, Ahern MJ, Roberts-Thomson PJ. Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. Asian Pac J Allergy Immunol. 1998;16:81\u20136.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"45_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1046\/j.1365-4362.1997.00088.x","volume":"36","author":"T Ohtsuka","year":"1997","unstructured":"Ohtsuka T, Hasegawa A, Nakano A, Yamakage A, Yamaguchi M, Miyachi Y. Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis. Int J Dermatol. 1997;36:116\u201322.","journal-title":"Int J Dermatol"},{"key":"45_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"45_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630\u201340.","journal-title":"Arthritis Rheum"},{"key":"45_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/art.1780230208","volume":"23","author":"HR Maricq","year":"1980","unstructured":"Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980;23:183\u20138.","journal-title":"Arthritis Rheum"},{"key":"45_CR29","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/acr.22054","volume":"65","author":"JY Sekiyama","year":"2013","unstructured":"Sekiyama JY, Camargo CZ, Andrade LE, Kayser C. Reliability of Widefield Nailfold Capillaroscopy and Videocapillaroscopy in the assessment of patients with Raynaud's Phenomenon. Arthritis Care Res. 2013;65:1853\u201361.","journal-title":"Arthritis Care Res"},{"key":"45_CR30","volume-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","author":"The Criteria Committee of the New York Heart Association","year":"1994","unstructured":"The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Lippincott Williams and Wilkins; 1994.","edition":"9"},{"key":"45_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1191\/0961203302lu144oa","volume":"11","author":"RN Furtado","year":"2002","unstructured":"Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus. 2002;11:35\u201341.","journal-title":"Lupus"},{"key":"45_CR32","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/rheumatology\/keq139","volume":"49","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Moore TL, Murray AK, Whidby N, Manning JB, Bhushan M, et al. Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischemia. Rheumatology. 2010;49:1776\u201382.","journal-title":"Rheumatology"},{"key":"45_CR33","first-page":"1923","volume":"26","author":"EK Li","year":"1999","unstructured":"Li EK, Tam LS. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol. 1999;26:1923\u20139.","journal-title":"J Rheumatol"},{"key":"45_CR34","first-page":"1292","volume":"17","author":"RA Asherson","year":"1990","unstructured":"Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990;17:1292\u20138.","journal-title":"J Rheumatol"},{"key":"45_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/0961203307080629","volume":"16","author":"A Kasparian","year":"2007","unstructured":"Kasparian A, Floros A, Gialafos E, Kanakis M, Tassiopoulos S, Kafasi N, et al. Raynaud\u2019s phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus. 2007;16:505\u20138.","journal-title":"Lupus"},{"key":"45_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3904\/kjim.2015.30.2.232","volume":"30","author":"HK Min","year":"2015","unstructured":"Min HK, Lee JH, Jung SM, Lee J, Kang KY, Kwok SK, et al. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Korean J Intern Med. 2015;30:232\u201341.","journal-title":"Korean J Intern Med"},{"key":"45_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00296-009-1255-2","volume":"31","author":"A Cefle","year":"2011","unstructured":"Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, et al. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int. 2011;31:183\u20139.","journal-title":"Rheumatol Int"},{"key":"45_CR38","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00296-012-2525-y","volume":"33","author":"YK Xia","year":"2013","unstructured":"Xia YK, Tu SH, Hu YH, Wang Y, Chen Z, Day HT, et al. Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population. Rheumatol Int. 2013;33:1211\u20137.","journal-title":"Rheumatol Int"},{"key":"45_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4137\/CMAMD.S7667","volume":"4","author":"SR Kamel","year":"2011","unstructured":"Kamel SR, Omar GM, Darwish AF, Asklany HT, Ellabban AS. Asymptomatic pulmonary hypertension in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2011;4:77\u201386.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"45_CR40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.7326\/0003-4819-106-4-524","volume":"106","author":"M Petri","year":"1987","unstructured":"Petri M, Rheinschmidt M, Whiting-O\u2019Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med. 1987;106:524\u201331.","journal-title":"Ann Intern Med"},{"key":"45_CR41","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s10067-006-0206-5","volume":"25","author":"SM Chung","year":"2006","unstructured":"Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol. 2006;25:866\u201372.","journal-title":"Clin Rheumatol"},{"key":"45_CR42","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493\u2013537.","journal-title":"Eur Heart J"},{"key":"45_CR43","first-page":"282","volume":"29","author":"E Tanaka","year":"2002","unstructured":"Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol. 2002;29:282\u20137.","journal-title":"J Rheumatol"},{"key":"45_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1378\/chest.130.1.182","volume":"130","author":"O Sanchez","year":"2006","unstructured":"Sanchez O, Sitbon O, Ja\u00efs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest. 2006;130:182\u20139.","journal-title":"Chest"},{"key":"45_CR45","doi-asserted-by":"crossref","unstructured":"Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013;65:3194\u2013201.","DOI":"10.1002\/art.38172"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-018-0045-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T19:11:39Z","timestamp":1578251499000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-018-0045-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1186\/s42358-018-0045-5","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,6]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local research ethics committee at the Federal University of S\u00e3o Paulo (no. 503,630). All patients gave their informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1"}}